Adient (NYSE:ADNT) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Adient (NYSE:ADNTGet Free Report) had its price objective lifted by analysts at Stifel Nicolaus from $24.00 to $26.00 in a report issued on Friday, MarketBeat.com reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price target suggests a potential upside of 20.40% from the company’s previous close.

Several other brokerages have also issued reports on ADNT. Wall Street Zen lowered shares of Adient from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. JPMorgan Chase & Co. lowered their target price on Adient from $26.00 to $24.00 and set a “neutral” rating on the stock in a research report on Thursday, November 6th. Wells Fargo & Company boosted their price target on Adient from $28.00 to $29.00 and gave the company an “overweight” rating in a report on Monday, January 12th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Adient in a research note on Wednesday. Finally, Citigroup lowered their price objective on Adient from $25.00 to $22.50 and set a “neutral” rating on the stock in a research report on Wednesday, November 12th. Three equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Adient presently has a consensus rating of “Hold” and an average target price of $24.56.

Check Out Our Latest Stock Analysis on ADNT

Adient Price Performance

NYSE ADNT opened at $21.59 on Friday. The company has a debt-to-equity ratio of 1.16, a current ratio of 1.12 and a quick ratio of 0.93. Adient has a 1-year low of $10.04 and a 1-year high of $26.16. The stock has a market capitalization of $1.69 billion, a price-to-earnings ratio of -6.47, a PEG ratio of 0.71 and a beta of 1.61. The business’s fifty day moving average price is $19.77 and its 200-day moving average price is $22.05.

Adient (NYSE:ADNTGet Free Report) last posted its earnings results on Wednesday, November 5th. The company reported $0.52 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.03). The firm had revenue of $3.68 billion during the quarter, compared to the consensus estimate of $3.58 billion. Adient had a negative net margin of 1.93% and a positive return on equity of 7.81%. The firm’s revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.68 EPS. On average, equities analysts predict that Adient will post 1.76 earnings per share for the current year.

Insider Transactions at Adient

In related news, EVP Michel Pierre Rose Berthelin sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $19.71, for a total value of $49,275.00. Following the transaction, the executive vice president directly owned 116,425 shares of the company’s stock, valued at approximately $2,294,736.75. The trade was a 2.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.72% of the company’s stock.

Hedge Funds Weigh In On Adient

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Adient by 3.9% in the 3rd quarter. Vanguard Group Inc. now owns 4,475,944 shares of the company’s stock worth $107,781,000 after acquiring an additional 166,319 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Adient by 8.5% in the third quarter. Dimensional Fund Advisors LP now owns 4,215,764 shares of the company’s stock worth $101,517,000 after purchasing an additional 328,555 shares during the last quarter. Pzena Investment Management LLC raised its stake in Adient by 7.0% during the second quarter. Pzena Investment Management LLC now owns 4,174,493 shares of the company’s stock valued at $81,236,000 after purchasing an additional 272,920 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in Adient by 61.3% during the third quarter. Arrowstreet Capital Limited Partnership now owns 1,890,233 shares of the company’s stock valued at $45,517,000 after purchasing an additional 718,538 shares during the last quarter. Finally, Letko Brosseau & Associates Inc. purchased a new position in shares of Adient in the 2nd quarter worth $28,839,000. 92.44% of the stock is owned by institutional investors.

About Adient

(Get Free Report)

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.

Read More

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.